The recent news that Angelina Jolie tested positive for the
BRCA1 mutation and has consequently undergone a prophylactic double
mastectomy to guard against developing breast cancer has increased
the intensity of the spotlight on the gene patent debate currently
playing out in both the United States Supreme Court in
Association for Molecular Pathology v. Myriad Genetics,
Inc, and in the Full Federal Court of Australia in Cancer
Voices Australia v Myriad Genetics Inc.
In April 2013, the US Supreme Court heard arguments in relation
to the patentability of isolated human genes, which are claimed in
patents held by Myriad Genetics, Inc. A decision by the Supreme
Court is expected in June 2013. Earlier this year, we reported on
the landmark decision of the Federal Court that confirmed the
patentability of isolated nucleotide sequences (genes) in
Australia. This decision is currently under appeal. For more
information, refer to the article at the following link.